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Artiﬁcial metalloenzymes (ArMs hereafter) combine attractive features of both homogeneous catalysts and
enzymes and oﬀer the potential to implement new-to-nature reactions in living organisms. Herein we
present an E. coli surface display platform for streptavidin (Sav hereafter) relying on an Lpp-OmpA
anchor. The system was used for the high throughput screening of a bioorthogonal CpRu-based artiﬁcial
deallylase (ADAse) that uncages an allylcarbamate-protected aminocoumarin 1. Two rounds of directed
evolution aﬀorded the double mutant S112M–K121A that displayed a 36-fold increase in surface activity
vs. cellular background and a 5.7-fold increased in vitro activity compared to the wild type enzyme. The
crystal structure of the best ADAse reveals the importance of mutation S112M to stabilize the cofactor
conformation inside the protein.Introduction
A new generation of green, sustainable and biocompatible
catalysts is a prerequisite to produce the ne chemicals and
complex drugs of the future.1 ArMs consist of an organometallic
moiety anchored within a protein scaﬀold thereby combining
some of the most attractive features of both homogeneous
catalysis and biocatalysis. In the last two decades, numerous
reports have highlighted the potential of such biohybrid cata-
lysts: (i) to catalyze new-to-nature transformations in water at
room temperature, (ii) the possibility to improve the ArM's
performance via chemo-genetic or directed evolution optimi-
zation schemes, and (iii) their integration in enzymatic
cascades.2–5 Various strategies have been pursued toward the
assembly of ArMs either via repurposing of natural metal-
loproteins or by anchoring a synthetic metal cofactor within
a protein scaﬀold.6–11 Covalent-, dative- and supramolecular
anchoring strategies have all been pursued with varying degrees
of success.
The design and optimization process is most versatile when
a combination of (i) structure-based cofactor design, (ii) in silicosel, Mattenstrasse 24a, Basel CH-4002,
ch
logy, University College London, Gower
ineering, ETH Zurich, Mattenstrasse 26,
tion (ESI) available. See DOI:
hemistry 2018screening12,13 and (iii) directed evolution schemes are applied.
Directed evolution oﬀers virtually innite sampling of protein
space. In reality however, only a small fraction of the protein
sequence space can be assessed due to the limited throughput
of the screen.
The biotin-streptavidin technology ranks amongst the most
versatile platforms for the generation of ArMs.8,14,15 In the past,
the throughput of Sav-based ArMs screens has been limited by
the presence of cellular inhibitors (mainly glutathione),
poisoning the transition metal, thus requiring screening with
puried Sav samples. Two strategies have been introduced to
overcome this challenge: (i) addition of thiol scavengers to
cellular extracts16–18 and (ii) Sav secretion into E. coli's periplasm
that contains low concentrations of reduced thiols.19 As a proof-
of-principle, we demonstrated that a Sav-based articial met-
alloenzyme for ring-closing metathesis could be assembled and
evolved in the periplasm of E. coli.19 Integration of new-to-
nature reactions in a microbial organism oﬀers fascinating
perspectives in chemical- and synthetic biology. Sav-based ArMs
assembled in the periplasm however require the passive diﬀu-
sion of the biotinylated metal cofactor across the E. coli outer
membrane.
To circumvent this limitation, we reasoned that an E. coli
surface display might oﬀer an attractive means to assemble an
ArM while maintaining the critical phenotype–genotype linkage
to allow evolving the biohybrid catalyst. Towards this goal, we
identied the following challenges: (i) create a high-
performance bioorthogonal ArM, (ii) identify a uorogenic
substrate that is uncaged in the presence of low catalyst
concentrations (1 mM) in the presence of a living cell, (iii)
develop a platform to display Sav on E. coli's outer membrane,Chem. Sci., 2018, 9, 5383–5388 | 5383
Fig. 1 Artiﬁcial metalloenzyme displayed on the E. coli outer membrane. (a) Streptavidin is fused to the C-terminus of an Lpp-OmpA fragment.
Induction of Lpp-OmpA-Sav expression in the cytosol is followed by secretion into the periplasmic space and anchoring to the outer membrane.
For simplicity only one Sav monomer is displayed. (b) A biotinylated ruthenium catalyst [CpRu(QA-Biot)(OH2)] 3 binds to Sav to aﬀord an artiﬁcial
deallylase. (c) A ﬂuorescent aminocoumarin 2 is uncaged in the presence of ADAse on the E. coli surface.
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View Article Online(iv) demonstrate binding of the biotinylated cofactor on surface-
displayed Sav and (v) develop a uorescent assay, amenable to
high-throughput screening (Fig. 1).Results and discussions
Building on the reports of Meggers, Wender and Mascaren˜as,
we selected the CpRu(2-quinolinecarboxylate)-catalyzed uncag-
ing of an allylcarbamate-protected substrate as a model reac-
tion.20–23 This system is particularly attractive as the Ru-
catalyzed allylic substitution was shown to (i) tolerate
a cellular environment, (ii) remain active even at very low
catalyst concentration, (iii) require no additional external
nucleophile (either water or thiols (i.e. glutathione) act as
nucleophile to uncage the substrate in vivo) and (iv) be
bioorthogonal.
We selected the water-soluble uorogenic substrate 7-
allylcarbamate-4-sulfonyl coumarin (1 hereaer) to demon-
strate the feasibility of surface-displayed ArMs based on the
biotin-streptavidin technology (Fig. 1). We synthesized the
biotinylated quinoline ligand QA-Biot (see ESI† for details). The
activity of [CpRu(QA-Biot)(OH2)] 3, obtained upon in situ
complexation of the biotinylated ligand to [CpRu(CH3CN)3]
+,
was evaluated for the uncaging of substrate 1 (Fig. 1b, c and
S1†). The in vitro reaction performed best in phosphate-buﬀered
saline at pH 7.4 (Fig. S11†) producing 7 turnover numbers
(TON) aer 30 h (Fig. 3b and S13b†). The Sav-embedded catalyst
[CpRu(QA-Biot)(OH2)] 3$WT Sav (ADAse) performed 3.7-fold5384 | Chem. Sci., 2018, 9, 5383–5388better (26 TON) than the free cofactor [CpRu(QA-Biot)(OH2)] 3 at
0.2 mol% loading in WT Sav. The protein was applied in 2-fold
excess vs. cofactor 3 with respect to the free biotin binding sites
(i.e. 1 mM [CpRu(QA-Biot)(OH2)] 3 and 0.5 mM homotetrameric
Sav). The release of aminocoumarin 2 could be detected in the
presence of 1 mM ArM. Virtually no background activity was
observed in the absence of [CpRu(QA-Biot)(OH2)] 3 at pH 7.4.
Sav surface display
Having identied reaction conditions suitable for the in vitro
aminocoumarin 2 formation with an ADAse, we set out to
develop a Sav-display platform on the E. coli outer
membrane.24,25 Initial eﬀorts focused on the fusion construct
between Sav with autotransporter AIDA as reported by Pyun and
coworkers.26 As the expression levels proved rather low, we
turned our attention to the Lpp-OmpA anchor initially reported
by Georgiou et al.27–29
This anchor consists of the truncated E. coli lipoprotein Lpp
(residues 1–9) fused to the rst ve b-strands of outer
membrane protein OmpA (residues 46–159). Sav was fused to
the C-terminus of OmpA and directed towards the extracellular
space (Fig. S14 and S15†). Successful integration of Sav on the
outer membrane was highlighted by staining the cells with
a primary mouse-anti Sav antibody, followed by labeling with
a secondary uorescent antibody. The samples were analyzed by
ow cytometry (Fig. 2a) and uorescence microscopy (Fig. 2b).
Flow cytometry revealed a marked increase in uorescence in
the presence of cells with Sav displayed on the outer membraneThis journal is © The Royal Society of Chemistry 2018
Fig. 2 (a) Flow cytometry of immuno-stained E. coli cells expressing Sav in the cytoplasm (orange), periplasm (blue) or on the surface (green)
compared to the empty vector control (grey). Cells were labeled with a primary mouse anti-Sav-antibody followed by a ﬂuorescently-labeled
secondary goat-anti-mouse antibody. (b) Fluorescence microscopy of immuno-stained E. coli cells from (a). (c) Uncaging of ﬂuorogenic
substrate 1 with WT ADAse on E. coli's surface in absence (red) and presence (blue) of 0.2% L-arabinose that induces the overexpression and
display of WT Sav on E. coli's outer surface.
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View Article Onlinevs. cells with Sav localized either in the cytoplasm or in the
periplasm. As we anticipated that antibodies would not cross
the outer- or inner membrane, uorescence detected as a result
of antibody staining strongly supports that Sav is indeed dis-
played on the outer-membrane and oriented towards the
extracellular space. Minimally biphasic uorescence was
however also observed for the periplasmic Sav sample (i.e. using
the OmpA Sav construct that secretes Sav to E. coli's peri-
plasm19), suggesting partial antibody migration through the
permeabilized outer membrane. Similar eﬀects have been re-
ported in other Lpp-OmpA-labeling studies.30 Fluorescence
microscopy revealed E. coli uorescence labeling only in the
presence of cells with Sav displayed on the surface. Monitoring
surface Sav expression with a uorescently-labeled biotin (Biot-
ATTO565) yielded very similar results (Fig. S16†). Although the
oligomeric state of Sav was not assessed, we hypothesize that it
is displayed as a homotetramer as demonstrated for other
surface-displayed oligomeric proteins.31,32ADAse with surface-displayed Sav
Next, we tested the ADAse's activity with the surface-displayed
biohybrid catalyst. The Sav isoforms were expressed in E. coli
cells at 25 C for 4 h in a 96-well plate. The cells were harvested,
the pellets were washed with PBS and resuspended in the
cofactor buﬀer (2 mM 3 in PBS, pH 7.4). Aer incubation on ice
for 30 min, the cells were spun-down, the pellets were washed
twice with PBS and resuspended in the substrate buﬀer (500 mM
1 in PBS, pH 7.4) and the cells were incubated at 30 C for 16 h.
The formation of aminocoumarin 2 was quantied byThis journal is © The Royal Society of Chemistry 2018uorescence (excitation 395 nm, emission 460 nm; see ESI†). To
our delight, the surface-displayed ArMs revealed ADAse activity.
The ADAse [CpRu(QA-Biot)(OH2)] 3$WT Sav had a 1.5-fold
increase over cellular background (Fig. S18†). Importantly,
catalysis for 16 h did not stall the viability of E. coli cells as
highlighted by cell growth on LB-agar plates (Fig. S19†).
Taken together, uorescence labeling and catalysis experi-
ments with Lpp-OmpA-Sav demonstrate that (i) streptavidin is
expressed and displayed on the outer membrane of E. coli, (ii)
the surface-displayed Sav maintains its biotin-binding activity
towards both Biot-ATTO565 as well as a biotinylated ruthenium
complex [CpRu(QA-Biot)(OH2)] 3, (iii) the surface-displayed
ADAse is functional and (iv) cells are viable aer catalysis.
With a 96-well plate uorimetric screen at hand (Fig. 3a), we
set out to genetically evolve the surface-displayed ADAse.
Previous Sav-ArM evolution campaigns highlighted the poten-
tial of iterative site saturation mutagenesis at positions S112
and K121 which lie in the immediate proximity of the catalytic
moiety.17–19 We thus generated a saturation mutagenesis library
at position Sav K121X (see ESI†).33 Several Sav mutants dis-
played increased surface ADAse activity vs. WT Sav: Sav K121S
(7.2-fold), Sav K121A (6.4-fold) and Sav K121M (2.6-fold)
(Fig. S18†). Removal of the basic lysine in position K121 thus
appears to be benecial. The three best Sav single mutants (i.e.
K121S, K121A and K121M) identied in the surface-display
screen were subjected to saturation mutagenesis at position
S112 and the ADAse activity of the corresponding three libraries
(i.e. Sav S112X–K121S, Sav S112X–K121A and Sav S112X–K121M)
was analyzed by uorescence using the surface-displayed Sav
double mutants in a 96 well plate format. For each of these threeChem. Sci., 2018, 9, 5383–5388 | 5385
Fig. 3 High-throughput screening on E. coli's surface to optimize ADAse activity. (a) 96-well plate screen. (b) Summary of the results from the
directed evolution of ADAses on E. coli's surface (blue bars) and catalysis with puriﬁed Sav mutants (gold bars) identiﬁed using the surface-display
screen. Reaction conditions with puriﬁed Sav samples: 500 mM substrate 1, 0.2 mol% cofactor 3, 0.4 mol% Savmonomer, 30 h, RT. (c) Crystal
structure of an evolved ADAse [CpRu(QA-Biot)(OH2)] 3$Sav S112M–K121A (PDB 6FH8). The protein is displayed as solvent-accessible surface and
the cofactor and residues S112M and K121A as stick models. The cofactor 3 is contoured with electron density of a 2FoFc map in blue (1s) and an
anomalous dispersion density in red (4s). The ruthenium is displayed as a turquoise sphere. The ligands highlighted inmagenta were not included
in the structure reﬁnement as no electron density could be unambiguously identiﬁed. Only one cofactor within the bis-biotin binding vestibule is
depicted for clarity.
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View Article Onlinelibraries, this straightforward screen allowed us to identify
double mutants with increased surface-displayed ADAse
activity: the two best second generation mutants Sav S112Y–
K121S and S112M–K121A yielded 25- and 24-fold increased
activity vs. WT ADAse, respectively. The best hit resulting from
library S112X–K121M was S112Q–K121M aﬀording a 17-fold
improved activity vs. the WT ADAse, respectively (Fig. 3b and
S18†). We conclude that bulky and polar residues at position
Sav S112 lead to improved ADAse activity. Importantly, the
activity of the best surface-displayed ADAse was 37-fold larger
vs. the empty vector control. A linear reaction rate of surface-
displayed ADAse for at least 16 h demonstrates the longevity
of this hybrid system (Fig. S13a†). To investigate potential
cofactor accumulation inside cells and degradation of the
surface-displayed ADAse, we incubated cells carrying either an
empty plasmid or the Sav S112Y–K121S plasmid with excess
cofactor 3 for 10, 30, 60 and 120min before washing. The ADAse
activity of the cells carrying the empty vector did not change
even following a two hour incubation with the [CpRu(QA-
Biot)(OH2)] 3 cofactor (Fig. S20†). This suggests that the cofactor
does not accumulate in the cells over time. Gratifyingly, the
S112Y–K121S ADAsemaintained its activity even aer two hours5386 | Chem. Sci., 2018, 9, 5383–5388incubation. This supports our hypothesis that no detectable
surface-displayed ADAse degradation takes place.Catalysis with puried ADAses
Next, we expressed the best single (K121S, K121A and K121M)
and three best double Sav mutants (i.e. Sav S112Y–K121S, Sav
S112M–K121A and Sav S112Q–K121M) in the cytoplasm, and
puried them by aﬃnity chromatography (see ESI†). The in vitro
activity ranking of the best Sav single mutants slightly changed
to K121A > K121S > K121M and the activity improvement vs.WT
was less pronounced than in the surface-display screen (2.4-,
2.0- and 1.3-fold, respectively, Fig. 3b). The double mutant
S112M–K121A displayed the highest activity in vitro. The TON
increase vs. WT was 5.7-fold. The puried ADAses displayed
a linear reaction rate for 30 h, which is similar to the corre-
sponding surface-displayed enzymes (Fig. S13b). To correlate
the activities of the evolved ADAses in puried form and on-
cells, we determined the relative expression yield of surface-
displayed Sav using Biot-ATTO565 staining followed by ow
cytometry (Fig. S17). All cells with surface-displayed Sav
mutants displayed a uorescence between 5- and 9-fold higherThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinethan the empty vector control. Upon normalization of the on-
cell activity for Sav expression, the order of the most active
mutants remained the same as determined without this
normalization procedure (Fig. 3b and S18†). Accordingly, the
best surface-displayed ADAses [CpRu(QA-Biot)(OH2)] 3$Sav
S112Y–K121S and 3$Sav S112M–K121A are 22- and 21-fold more
active than the WT ADAse.X-ray structure
In order to elucidate the localization of [CpRu(QA-Biot)(OH2)]
3 within Sav, we sought to gain X-ray structural insight. To our
delight, [CpRu(QA-Biot)(OH2)] 3$Sav-S112M–K121A aﬀorded
high resolution diﬀraction data. The crystals were obtained by
sitting drop vapor diﬀusion, followed by soaking with cofactor
[CpRu(QA-Biot)(OH2)] 3 and ash freezing in liquid nitrogen
(see ESI†). The [CpRu(QA-Biot)(OH2)] 3 cofactor was modeled
with 100% occupancy within the Sav biotin binding site
(Fig. 3c and S21†). The piperazine linker and the ruthenium
carboxyquinoline moiety are localized in a single conforma-
tion within the biotin vestibule. The aromatic quinoline ring
is stabilized by a methionine–p interaction with the neigh-
boring S112M side chain.34 The aliphatic side chains of L124
and L124* (* indicates the neighboring Sav monomer) and the
carbonyl moieties of residues K121A and S122 form a pocket
that harbors the quinoline ligand. Spherically-shaped electron
density around the ruthenium suggests that the cofactor may
exist as a mixture of epimers (i.e. (R)- and (S)-Ru). The Cp and
water ligands were thus not modeled due to the ambiguity of
the electron density.Conclusions
We evolved an articial allylic deallylase based on the biotin-
streptavidin technology that catalyzes the uncaging of a uoro-
genic allylcarbamate-protected coumarin 1. The reaction
proceeds smoothly even at 1 mM catalyst concentration. To
streamline the directed evolution protocol, we implemented an
E. coli outer membrane display using the Lpp-OmpA-Sav fusion
construct. Amino-acid substitutions at positions S112 and K121
lead to a twenty-one-fold improvement in normalized surface
ADAse activity (i.e. Sav S112M–K121A) vs. WT. The Sav muta-
tions accelerating ADAse activity on the E. coli surface also have
a benecial eﬀect on puried Sav samples in vitro yielding an up
to 5.7-fold increased TON (Sav S112M–K121A) vs. WT. E. coli
cells are viable aer 16 h catalysis. X-ray crystallography of
ADAse double mutant S112M–K121A highlights the localization
of cofactor 3 within the biotin-binding vestibule. We anticipate
that this straightforward protein-display strategy can readily be
extended to signicantly simplify the directed evolution of
articial metalloenzymes for in vivo synthetic biology
applications.Conﬂicts of interest
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